Business Context and Reporting Period
Company: Astro-Med, Inc. (Note: Input metadata referenced "Astronova, Inc.", but the filing text identifies the registrant as Astro-Med, Inc.)
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Quarter and nine months ended October 28, 1995.
Business Overview: The company manufactures medical equipment. In August 1994, it acquired Grass Instrument Co. and Cannon Manufacturing Company, which are now reported as a wholly-owned subsidiary.
Key Financial Metrics
| Metric | Q3 1995 | Q3 1994 | 9 Months 1995 | 9 Months 1994 |
|---|---|---|---|---|
| Net Sales | $10,823,820 | $11,220,838 | $32,566,709 | $26,865,409 |
| Gross Profit | $4,236,181 | $4,967,170 | $13,092,790 | $12,055,075 |
| Gross Margin % | 39% | 44% | 40% | 45% |
| Operating Income | $398,260 | $1,188,841 | $1,154,194 | $1,953,034 |
| Net Income | $280,371 | $892,249 | $1,148,307 | $1,744,012 |
| Earnings Per Share | $0.06 | $0.18 | $0.23 | $0.34 |
| Cash & Equivalents (End of Period) | $1,508,725 (as of Oct 28, 1995) | |||
| Operating Cash Flow (9 Months) | $1,119,543 | |||
| Total Debt (Current + Long-Term) | $245,775 (Current: $251,703; Long-Term: $194,072) |
Material Changes vs. Prior Period
- Revenue: Q3 sales decreased 4% year-over-year due to a comparison against an unusually high sales quarter for the newly acquired Grass Instrument Co. business in the prior year. However, nine-month sales increased 21% year-over-year (4% organic growth excluding the new business).
- Profitability: Gross margins declined from 44% to 39% in Q3 and from 45% to 40% for the nine months. Management attributes this to lower volume leading to unfavorable overhead absorption and the inclusion of the new business, which historically has lower margins.
- Expenses: Selling, General, and Administrative (SG&A) expenses increased 5% in Q3 and 9% (excluding the new business) for the nine months, driven by increased advertising and additional sales personnel.
- Investment Income: Interest and dividend income decreased significantly due to reduced invested cash following the cash acquisition of the new business.
Guidance, Outlook, and Risks
- Outlook: Management anticipates an overall sales increase in the fourth quarter of the fiscal year and expects a corresponding increase in gross profit.
- Liquidity: The company states that current cash, investment securities, and funds from operations are sufficient to meet working capital needs for the foreseeable future. No additional long-term financing is planned.
- Inventory: An increase in inventory levels is noted as being in accordance with business plans.
- Risks/Contingencies: The filing does not explicitly detail specific legal contingencies or unusual items beyond the standard operational risks associated with margin compression and volume fluctuations.
Investor Verification Checklist
- Margin Sustainability: Verify if the 39% gross margin in Q3 is a temporary volume issue or a structural decline due to the lower-margin acquired business.
- Inventory Turnover: Confirm that the $1.1 million increase in inventory (to $13.99M) aligns with the anticipated Q4 sales growth and does not signal obsolescence.
- Organic Growth: Validate the management claim of 4% organic sales growth for the nine-month period by reviewing product-line specific data if available.
- Debt Structure: Review the terms of the industrial development revenue bond financing to ensure no immediate refinancing risks exist.